Moderna, the biotechnology firm partnering with the National Institutes of Health to develop a coronavirus vaccine, announced Thursday that it has fully enrolled its trial, with 30,000 participants more than a third of whom are minorities. The coronavirus vaccine trials have been closely watched to ensure they reflect the diversity of the U.S.